HomeERNA • NASDAQ
Ernexa Therapeutics Inc
Follow
$0.19
4.48%
After Hours:(0.26%)+0.00050
$0.19
Closed: Apr 4, 6:01:28 PM GMT-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.00K | -94.12% |
Operating expense | 2.70M | -52.80% |
Net income | -5.76M | 6.40% |
Net profit margin | -575.90K | -1,491.14% |
Earnings per share | — | — |
EBITDA | -2.68M | 53.37% |
Effective tax rate | -0.19% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.73M | -77.17% |
Total assets | 5.27M | -89.28% |
Total liabilities | 3.57M | -92.39% |
Total equity | 1.70M | — |
Shares outstanding | 52.24M | — |
Price to book | 6.03 | — |
Return on assets | -103.83% | — |
Return on capital | 253.95% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.76M | 6.40% |
Cash from operations | -3.55M | 23.94% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 1.01M | -86.89% |
Net change in cash | -2.54M | -183.83% |
Free cash flow | -2.52M | 62.42% |
Previous close
$0.18
Day range
$0.15 - $0.19
Year range
$0.15 - $2.63
Market cap
1.19B USD
Avg Volume
206.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1984
Headquarters
Website
Employees
6
